BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor

about

BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor

Item

http://www.wikidata.org/entity/Q58702370

description

im November 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 21 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

BPR1J373, a novel multitargete ...... gastrointestinal stromal tumor

@en

BPR1J373, a novel multitargete ...... gastrointestinal stromal tumor

@nl

type

Item

label

BPR1J373, a novel multitargete ...... gastrointestinal stromal tumor

@en

BPR1J373, a novel multitargete ...... gastrointestinal stromal tumor

@nl

prefLabel

BPR1J373, a novel multitargete ...... gastrointestinal stromal tumor

@en

BPR1J373, a novel multitargete ...... gastrointestinal stromal tumor

@nl

P1476

BPR1J373, a novel multitargete ...... gastrointestinal stromal tumor

@en

P2093

Chiung-Tong Chen

http://www.w3.org/2001/XMLSchema#string

Chun-Chieh Wu

http://www.w3.org/2001/XMLSchema#string

Hui-You Lin

http://www.w3.org/2001/XMLSchema#string

Jonathan A Fletcher

http://www.w3.org/2001/XMLSchema#string

Li-Tzong Chen

http://www.w3.org/2001/XMLSchema#string

Ming-Jon Lin

http://www.w3.org/2001/XMLSchema#string

Ming-Yu Yang

http://www.w3.org/2001/XMLSchema#string

Neng-Yao Shih

http://www.w3.org/2001/XMLSchema#string

Tsu-An John Hsu

http://www.w3.org/2001/XMLSchema#string

Weir-Torn Jiaang

http://www.w3.org/2001/XMLSchema#string

P2860

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate.

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

P304

3591-3601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13773

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Hui-Jen Tsai

P577

2018-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30142229

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6215875

http://www.w3.org/2001/XMLSchema#string